Alnylam Pharmaceuticals (ALNY) Price to Earnings (2009 - 2026)

Alnylam Pharmaceuticals (ALNY) Price to Earnings (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) P/E
1 Oculis Holding AG 65,719.23 Bn 65,718.94 Bn - -30.67 Bn
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -70,009.43
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -32,669.10
4 BeOne Medicines 471.85 Bn 467.06 Bn 1.35 Bn 919.76
5 Vertex Pharmaceuticals 122.29 Bn 115.04 Bn 2.59 Bn 28.19
6 Regeneron Pharmaceuticals 70.04 Bn 61.28 Bn 3.31 Bn 15.83
7 Belite Bio 62.06 Bn 62.06 Bn - 365.08 Bn
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn 32.52
9 Alnylam Pharmaceuticals 37.47 Bn 34.47 Bn 959.66 Mn 68.89
10 Revolution Medicines 37.17 Bn 37.17 Bn - -27.10

Historic Data

Download Data
DateValue
Jul 23, 2026 65.66
Jul 22, 2026 65.23
Jul 21, 2026 66.30
Jul 20, 2026 66.62
Jul 17, 2026 65.35
Jul 16, 2026 69.18
Jul 15, 2026 68.20
Jul 14, 2026 68.72
Jul 13, 2026 70.38
Jul 10, 2026 72.99
Jul 9, 2026 76.42
Jul 8, 2026 79.04
Jul 7, 2026 78.57
Jul 6, 2026 76.48
Jul 2, 2026 76.42
Jul 1, 2026 73.70
Jun 30, 2026 73.55
Jun 29, 2026 71.71
Jun 26, 2026 71.19
Jun 25, 2026 71.63